Literature DB >> 2543472

Isolated pericardial relapse following allogeneic bone marrow transplantation for acute myelogenous leukemia.

H Einsele1, G Ehninger, A Vallbracht, J Kömpf, H Schmidt, R Kandolf, G Jahn, C Müller.   

Abstract

A 34-year-old male patient developed an isolated pericardial relapse of an acute myelogenous leukemia (M3) 11 months after marrow grafting from his HLA-identical brother. Alloenzyme pattern analysis revealed recipient type of the myeloblasts obtained from the pericardial effusion. Recurrence of the original leukemia was preceded by a reactivation of latent cytomegalovirus (CMV) infection which, in spite of a systemic humoral immune response to the virus, persisted in the pericardium as shown by dot-blot hybridization using CMV-specific DNA fragments. Activated T cells propagated with IL-2 from the pericardial effusion did not reveal any cytotoxic or restimulation capacity on the original or relapse myeloblasts, nor on other donor, recipient or NK target cells. Local coincidence of virus persistence and leukemic relapse suggested CMV-mediated modulation of the immune response in the pericardium with consequent induction of a proliferation of the original malignant cell clone. After local chemotherapy and one course of systemic treatment the patient is still in complete remission--longer than after the marrow grafting.

Entities:  

Mesh:

Year:  1989        PMID: 2543472

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  4 in total

Review 1.  Filgrastim treatment of acute myelogenous leukemia (M7) relapse after allogeneic peripheral stem cell transplantation resulting in both graft-versus-leukemia effect with cytogenetic remission and chronic graft-versus-host disease manifesting as polyserositis and subsequent bronchiolitis obliterans with organizing pneumonia.

Authors:  L Law; J Tuscano; T Wun; K Ahlberg; C Richman
Journal:  Int J Hematol       Date:  2002-11       Impact factor: 2.490

2.  Pericardial effusion post transplantation predicts inferior overall survival following allo-hematopoietic stem cell transplant.

Authors:  X Chen; Q Zou; J Yin; C Wang; J Xu; J Wei; Y Zhang
Journal:  Bone Marrow Transplant       Date:  2015-10-19       Impact factor: 5.483

3.  Comparison of different techniques for detection of cytomegalovirus infection following bone marrow transplantation.

Authors:  H Einsele; A Vallbracht; C A Müller
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-08       Impact factor: 3.267

4.  Cardiac Relapse of Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  María Facenda-Lorenzo; Ana Sánchez-Quintana; Alejandro Quijada-Fumero; Ana Laynez-Carnicero; Joaquín Breña-Atienza; Francisco J Poncela-Mireles; Juan M Llanos-Gómez; Ana I Cabello-Rodríguez; María Ramos-López
Journal:  Case Rep Oncol Med       Date:  2016-08-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.